Reliant Pharmaceuticals
Industry | Pharmaceuticals |
---|---|
Defunct | December 2007 (2007-12) |
Fate | Acquired by GlaxoSmithKline |
Key people | Joseph J. Krivulka (co-founder) |
Reliant Pharmaceuticals was a company purchased by GlaxoSmithKline in December 2007 for $1.65B.[1] Co-founded by Joseph J. Krivulka.
It was known for six major products, including Lovaza (Omega-3), Axid (H2 blocker), Dynacirc CR (calcium channel blocker), Antara (fenofibrate), InnoPran XL (beta blocker), Lescol XL (Fluvastatin), and Rythmol SR (Class IC anti-arrhythmic).
Reliant Pharmaceuticals, Inc. was a pharmaceutical company that specialized in the development, commercialization and marketing of prescription therapeutic products. Reliant marketed six cardiovascular products in the United States and focused on promoting its products to targeted primary care and specialty physicians, as well as selected hospitals and academic centers in the United States. Reliants' sales force consisted of approximately 650 sales and marketing professionals nationwide.
In 2007, Reliant Pharmaceuticals was acquired by GSK for $1.65 billion in cash, after Reliant recorded net sales of $341 million in the nine months leading to September 30, 2007.[2] The Lovaza drug accounted for 60% of the sales of the company for that period.[3]
References
- ^ Reliant Redirect – GlaxoSmithKline
- ^ "GSK to Acquire Reliant Pharmaceuticals for $1.65B". GEN - Genetic Engineering and Biotechnology News. 2007-11-21. Retrieved 2019-10-21.
- ^ Van Arnum, Patricia (2007-11-29). "GlaxoSmithKline to Acquire Reliant Pharmaceuticals for $1.65 Billion". PharmaTech. Retrieved 2019-10-21.
- v
- t
- e
Current |
|
---|---|
Defunct |
|
regulatory bodies
- Commission on Human Medicines
- Department of Health
- European Directorate for the Quality of Medicines & HealthCare
- Medicines and Healthcare products Regulatory Agency
- National Collaborating Centre for Mental Health
- Pharmaceutical Price Regulation Scheme
- Pharmaceutical Society of Northern Ireland
- General Pharmaceutical Council
- Scottish Medicines Consortium
- Veterinary Medicines Directorate
professional bodies
- Association of the British Pharmaceutical Industry
- Chemical Industries Association
- European Federation of Biotechnology
- European Federation of Pharmaceutical Industries and Associations
- Faculty of Pharmaceutical Medicine
- Pharmacists' Defence Association
- Royal Pharmaceutical Society of Great Britain
- Worshipful Society of Apothecaries
- category
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e